4//SEC Filing
Midatech Pharma US Inc. 4
Accession 0001354488-15-005393
CIK 0000919745operating
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 7:51 AM ET
Size
31.5 KB
Accession
0001354488-15-005393
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Disposition to Issuer
Stock Option
2015-12-04−43,333→ 0 totalExercise: $5.00From: 2015-12-04Exp: 2023-01-18→ Common Stock (43,333 underlying) - Disposition to Issuer
Stock Option
2015-12-04−375→ 0 totalExercise: $36.00From: 2012-03-23Exp: 2020-03-23→ Common Stock (375 underlying) - Disposition to Issuer
Stock Option
2015-12-04−2,000→ 0 totalExercise: $10.25From: 2012-09-15Exp: 2021-09-15→ Common Stock (2,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−80,000→ 0 totalExercise: $0.69From: 2019-05-19Exp: 2025-05-19→ Common Stock (80,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−100,000→ 0 totalExercise: $2.90From: 2015-12-04Exp: 2024-03-04→ Common Stock (100,000 underlying) - Disposition to Issuer
Warrants
2015-12-04−22,523→ 0 totalExercise: $1.67From: 2014-06-04Exp: 2019-06-04→ Common Stock (22,523 underlying) - Disposition to Issuer
Stock Option
2015-12-04−1,000→ 0 totalExercise: $15.15From: 2011-08-02Exp: 2021-04-01→ Common Stock (1,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−10,000→ 0 totalExercise: $5.00From: 2015-12-04Exp: 2022-05-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Preferred Stock
2015-12-04−50→ 0 totalExercise: $0.00From: 2014-06-04→ Common Stock (45,045 underlying) - Disposition to Issuer
Common Stock
2015-12-04−20,614→ 0 total - Disposition to Issuer
Stock Option
2015-12-04−75,000→ 0 totalExercise: $6.55From: 2011-12-27Exp: 2021-12-27→ Common Stock (75,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−80,000→ 0 totalExercise: $5.05From: 2015-12-04Exp: 2023-02-28→ Common Stock (80,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−371,000→ 0 totalExercise: $0.79From: 2015-12-04Exp: 2025-02-09→ Common Stock (371,000 underlying)
Footnotes (5)
- [F1]Common stock disposed of pursuant to the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA) and Midatech Pharma PLC (Midatech) and certain other parties thereto, whereby each share of common stock of DARA was converted into (i) 0.136 American Depository Receipts (Midatech ADRs), with each Midatech ADR representing two Midatech ordinary shares, plus (ii) one contingent value right representing the right to receive contingent payments if specified milestones are achieved within agreed time periods, plus (iii) cash in lieu of fractional Midatech ADRs. The closing price of the Midatech ordinary shares on December 4, 2015, the effective date of the merger was ?2.65.
- [F2]These options were assumed by Midatech in connection with the Merger and replaced with options to purchase 0.136 Midatech ADRs for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136.
- [F3]These preferred shares were purchased by Midatech pursuant to the merger agreement for $1,000 per share for total consideration of $50,000.
- [F4]These preferred shares have no expiration date.
- [F5]These warrants were assumed by Midatech in connection with the Merger and replaced with warrants to purchase 0.136 Midatech ADRs for each warrant held at an exercise price equivalent to the exercise price of a DARA option divided by 0.136.
Documents
Issuer
Midatech Pharma US Inc.
CIK 0000919745
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000919745
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 7:51 AM ET
- Size
- 31.5 KB